EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Telemonitoring in Inflammatory Bowel Disease: Findings from the TIGE-Rus Randomized Controlled Trial

Dina A Akhmedzyanova iD, Yuliya F Shumskaya iD, Kristina V Charaya iD, Yuriy A Vasilev, Anton V Vladzymyrskyy iD, Yulya A Alymova, Ivan A Blokhin iD, Roman V Reshetnikov, Irina V Kuprina, Olga V Taschyan, Marta V Yurazh, Marina G Mnatsakanyan

Journal of Clinical Medicine · 20.06.2026 · 15 (12) · 4800

DOI: 10.3390/jcm15124800 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.06.2026. Verfasst von Dina A Akhmedzyanova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moscow Healthcare Department, Scientific rationale, concept, and methodology for patient management using artificial intelligence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Telemedicine is increasingly used in inflammatory bowel disease (IBD), but its effects on quality of life (QoL) and psychological outcomes remain unclear.

Objectives

This study aimed to evaluate the impact of 6-month telemonitoring on QoL, disease activity, treatment adherence, psychological well-being, patient satisfaction, and healthcare utilization.

Methods

This randomized, open-label, single-center study conducted in Russia (July 2023–December 2024) included adults with ulcerative colitis or Crohn’s disease, who were assigned 1:1 to telemonitoring or standard care. The intervention involved monthly remote assessments and access to a web-based platform containing educational information, disease activity assessment, and a chat with a gastroenterologist. The primary outcome was health-related QoL (SIBDQ). Exploratory outcomes included general QoL (WHOQOL-26), psychological well-being (HADS), alexithymia (TAS-26), visceral sensitivity (VSI), treatment adherence (GMAS), patient satisfaction (PSQ-18), achievement of clinical remission, and healthcare utilization.

Results

Sixty-eight patients completed the study (32 intervention, 36 control). Telemonitoring was associated with lower anxiety levels (β = −1.76, p = 0.021), reduced visceral sensitivity (β = −5.08, p = 0.039), and higher medication adherence (β = 1.75, p = 0.008). No significant associations were observed for SIBDQ, WHOQOL-26 domains, depressive symptoms, alexithymia, achievement of clinical remission, or patient satisfaction with care (p > 0.05). Patients in the telemonitoring group also required fewer outpatient visits (p < 0.001), with no difference in hospitalizations. Within-group analysis demonstrated improvements in QoL, treatment adherence, visceral sensitivity, and disease activity in the telemonitoring group, but not in the controls.

Conclusions

Six-month telemonitoring in IBD was associated with lower anxiety, reduced visceral sensitivity, improved treatment adherence, and fewer outpatient visits. The health-related QoL assessed by the SIBDQ did not differ compared to standard care. No clear clinical disadvantage compared with standard care was detected during the study period.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseinflammatory bowel diseasemHealthtelemonitoringulcerative colitis

Autor:innen und Institutionen

  • Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia.
  • The First Sechenov Moscow State Medical University (Sechenov University), Moscow 119991, Russia.

ORCID-Profile: Dina A Akhmedzyanova, Yuliya F Shumskaya, Kristina V Charaya, Anton V Vladzymyrskyy, Ivan A Blokhin

Förderung

  • Moscow Healthcare Department
  • Scientific rationale, concept, and methodology for patient management using artificial intelligence

Zitieren

APA

Akhmedzyanova, D. A., Shumskaya, Y. F., Charaya, K. V., Vasilev, Y. A., Vladzymyrskyy, A. V., Alymova, Y. A., Blokhin, I. A., Reshetnikov, R. V., Kuprina, I. V., Taschyan, O. V., Yurazh, M. V., & Mnatsakanyan, M. G. (2026). Telemonitoring in Inflammatory Bowel Disease: Findings from the TIGE-Rus Randomized Controlled Trial. Journal of Clinical Medicine, 15(12), 4800. https://doi.org/10.3390/jcm15124800

Vancouver

Akhmedzyanova DA, Shumskaya YF, Charaya KV, Vasilev YA, Vladzymyrskyy AV, Alymova YA, et al. Telemonitoring in Inflammatory Bowel Disease: Findings from the TIGE-Rus Randomized Controlled Trial. Journal of Clinical Medicine. 2026;15(12):4800. doi:10.3390/jcm15124800

BibTeX
@article{Akhmedzyanova2026,
  author = {Akhmedzyanova, Dina A and Shumskaya, Yuliya F and Charaya, Kristina V and Vasilev, Yuriy A and Vladzymyrskyy, Anton V and Alymova, Yulya A and Blokhin, Ivan A and Reshetnikov, Roman V and Kuprina, Irina V and Taschyan, Olga V and Yurazh, Marta V and Mnatsakanyan, Marina G},
  title = {Telemonitoring in Inflammatory Bowel Disease: Findings from the TIGE-Rus Randomized Controlled Trial},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4800},
  doi = {10.3390/jcm15124800}
}
Kostenlos starten →